Paul J Clancy is of EXACT SCIENCES CORP. Currently has a direct ownership of 20,145 shares of EXAS, which is worth approximately $933,922. The most recent transaction as insider was on Jun 13, 2024, when has been sold 5,444 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.1K
37.03% 3M change
37.03% 12M change
Total Value Held $933,922

Paul J Clancy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2024
BUY
Grant, award, or other acquisition
-
5,444 Added 21.27%
20,145 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
3,599 Added 19.67%
14,701 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
5,606 Added 33.55%
11,102 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
-
2,567 Added 31.84%
5,496 Common Stock
Mar 18 2021
BUY
Grant, award, or other acquisition
-
2,929 Added 50.0%
2,929 Common Stock

Also insider at

INCY
INCYTE CORP Healthcare
AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
PJC

Paul J Clancy

Wilmington, DE

Track Institutional and Insider Activities on EXAS

Follow EXACT SCIENCES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS